Sepracor shifts Lunesta DTC biz

Share this article:

Sepracor has shifted its Lunesta DTC advertising business from McCann Erickson to Kaplan Thaler Group.

Since 2006, ads featuring Lunesta's moth have ranked tops in viewer recall, according to IAG Research, and Sepracor leads the industry in DTC spending as a result of its hefty outlays on the brand's behalf. From January 2006 through September 2007, Lunesta DTC spend totaled nearly $453 million, according to TNS Media Intelligence. By contrast, Sanofi-Aventis spent a scant $265 million on consumer ads for its Ambien franchise, and Takeda spent a paltry $171 million promoting Rozerem to consumers. 
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

More in Features

Journal Ad Review: Reality Bites

Journal Ad Review: Reality Bites

Print's numbers may be taking some small steps in the right direction, but data is what the industry really wants to sink its teeth into. Larry Dobrow reports on what ...

Headliner: Proteus CEO takes an original path

Headliner: Proteus CEO takes an original path

Andrew Thompson, CEO, Proteus Digital Health

Leadership Exchange: How Do We Get Beyond the Pill?

Leadership Exchange: How Do We Get Beyond the ...

As its focus moves from manufacturing to service, pharma needs to partner with healthcare neophytes as well as established players. James Chase asks six experts to assess the risks and ...